NewAmsterdam Pharma Co N.V.
NAMSW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $28.1M in total; no superinvestor holds it.
Other share classesNAMS
Q3 2024 vs. Q2 2024
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 1.30M | 1.33M | +34.5K (+2.7%) |
| Value | $11.5M | $9.32M | −$2.17M (−18.9%) |
New holders (1)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Monashee Investment Management LLC | 31,189 | $218.3K | 0.02% |
Sold out (0)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q2 2024 and filed for Q3 2024 without it.
None.